Home » Topics » Regulatory » Patents

Patents
RSS

New ropinirole formulation described by SKB

Jan. 29, 1997

Lilly claims new indications for olanzapine

Jan. 29, 1997

New use claimed for maprotiline

Jan. 29, 1997

Dual COX-2/5-LO inhibitors reported by Searle

Jan. 29, 1997

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

Antiulcer agents from Otsuka

Jan. 29, 1997

Banyu prepares selective muscarinic antagonists with reduced side effects

Jan. 29, 1997

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

Allelix develops antiinflammatory peptides

Jan. 29, 1997

HOP-1 claimed by Signal for treatment of CNS disorders

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.